Engineers Gate Manager’s Praxis Precision Medicines PRAX Stock Holding History

Engineers Gate Manager’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,606	Closed	-$288K	–	2462
2025 Q1	$288K	Buy	7,606 +3,756	+98%	+$235K	﹤0.01%	1735
2024 Q4	$296K	Sell	3,850 -887	-19%	-$64.2K	0.01%	1702
2024 Q3	$273K	Sell	4,737 -7,922	-63%	-$428K	0.01%	1662
2024 Q2	$524K	Buy	12,659 +8,415	+198%	+$398K	0.01%	1200
2024 Q1	$259K	Buy	+4,244	New	+$190K	0.01%	1536
2023 Q3	–	Sell	-1,299	Closed	-$22.4K	–	2025
2023 Q2	$22.4K	Buy	+1,299	New	+$19.9K	﹤0.01%	1663

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Engineers Gate Manager's PRAX Position: Q2 2025 in Review

Engineers Gate Manager sold out of Praxis Precision Medicines (PRAX) in Q2 2025, closing a stake of 7,606 shares — an estimated $288K sold.

Engineers Gate Manager first reported a position in PRAX in Q2 2023 and held it in 6 quarters. The position peaked at $524K in Q2 2024. 143 funds tracked by Wall St. Rank hold PRAX as of Q2 2025.

Engineers Gate Manager reported no remaining Praxis Precision Medicines position as of Q2 2025 after selling out during the quarter.
Engineers Gate Manager sold 7,606 Praxis Precision Medicines shares in Q2 2025, an estimated $288K.
Engineers Gate Manager first reported a position in Praxis Precision Medicines in Q2 2023 and held it in 6 quarters.
Engineers Gate Manager's Praxis Precision Medicines position peaked at $524K in Q2 2024.
143 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2025.

Based on Engineers Gate Manager's 13F filing for Q2 2025, filed 14 Aug 2025.